Oral Anticoagulants Market – Direct Oral Anticoagulants Dominate

adicionou um novo artigo Health

2026-09-11 09:54:12 -

Market Overview The oral anticoagulants market is being transformed by the dominance of direct oral anticoagulants (DOACs), which have largely replaced warfarin for many indications. DOACs offer fixed dosing, fewer food and drug interactions, and no routine monitoring. The market is projected to grow through 2030, driven by growing clinical evidence, patient preference, and generic...

0 Comentários 0 Compartilhamentos 33 Visualizações 0 Anterior